CONTENTS
Issue 71 | June 2018
Analysts are predicting a surge of M&A activity in the biotechnology space
Can the gene and cell therapy revolution be successfully scaled up?
One in four non-antibiotic drugs affect the growth of gut bacteria
A history of mumps and the drugs used to treat the disease
Why is Switzerland so conducive to pharmaceutical success?
Is the UK medical board responsible for approving new drugs outdated?
UK pharma could save billions through investing in digital tech
The industry is undergoing dramatic change as new tech brings disruption
Gene editing tool CRISPR/Cas9 has electrified the biotech industry